CWIG
VIR icon

Chung Wu Investment Group’s Vir Biotechnology VIR Stock Holding History

Chung Wu Investment Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.6K Buy
+3,410
New +$27.2K 0.03% 152

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Chung Wu Investment Group's VIR Position: Q1 2026 in Review

Chung Wu Investment Group opened a new position in Vir Biotechnology (VIR) in Q1 2026: 3,410 shares worth $30.6K. The stake represents 0.03% of the portfolio and ranks #152 among its holdings.

251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Chung Wu Investment Group held 3,410 shares of Vir Biotechnology worth $30.6K as of Q1 2026.
  • Vir Biotechnology was a new Chung Wu Investment Group position in Q1 2026.
  • Vir Biotechnology made up 0.03% of Chung Wu Investment Group's portfolio in Q1 2026, its #152 holding.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Chung Wu Investment Group's 13F filing for Q1 2026, filed 12 May 2026.